Codeine Plus Acetaminophen for Pain After Photorefractive Keratectomy: A Randomized, Double-Blind, Placebo-Controlled Add-On Trial

被引:1
|
作者
Pereira, Vinicius B. P. [1 ]
Garcia, Renato [1 ]
Torricelli, Andre A. M. [1 ]
Mukai, Adriana [1 ]
Bechara, Samir J. [1 ]
机构
[1] Univ Sao Paulo, Dept Ophthalmol, Med Sch, Gen Hosp, Sao Paulo, Brazil
关键词
opioids; photorefractive keratectomy; visual analog scale; pain; paracetamol; acetaminophen; codeine; POSTOPERATIVE PAIN; SURFACE ABLATION; OCULAR PAIN; DICLOFENAC; EFFICACY; GUIDELINES; SAFETY;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Pain after photorefractive keratectomy (PRK) is significant, and the analgesic efficacy and safety of oral opioids in combination with acetaminophen has not been fully investigated in PRK trials. Purpose: To assess the efficacy and safety of the combination of codeine plus acetaminophen (paracetamol) versus placebo as an addon therapy for pain control after PRK. Study design: Randomized, double-blind, placebo-controlled trial. Setting: Single tertiary center. Methods: One eye was randomly allocated to the intervention, whereas the fellow eye was treated with a placebo. Eyes were operated 2 weeks apart. The participants were adults older than 20 years with refractive stability for >= 1 year, who underwent PRK for correction of myopia or myopic astigmatism. Codeine (30 mg) plus acetaminophen (500 mg) was given orally 4 times per day for 4 days after PRK. The follow-up duration was 4 months. The study outcomes included pain scores at 1 to 72 hours, as measured by the visual analog scale, McGill Pain Questionnaire, and Brief Pain Inventory, as well as adverse events and corneal wound healing. Results: Of the initial 82 eyes, 80 completed the trial (40 intervention, 40 placebo). Median (interquartile range) pain scores as measured by the visual analog scale were statistically and clinically lower during treatment with codeine/acetaminophen compared with the placebo: 1 hour: 4 (2-4) versus 6 (3-6), P, 0.001; 24 hours: 4 (3-6) versus 7 (6-9), P < 0.001; 48 hours: 1 (02) versus 3 (2-5), P < 0.001; and 72 hours: 0 (0-0) versus 0 (0-2), P = 0.001. Virtually identical results were obtained by the McGill Pain Questionnaire and Brief Pain Inventory scales. The most common adverse events with codeine/acetaminophen were drowsiness (42%), nausea (18%), and constipation (5%). No case of delayed epithelial healing was observed in both treatment arms. Conclusions: When added to the usual care therapy, the oral combination of codeine/acetaminophen was safe and significantly superior to the placebo for pain control after PRK.
引用
收藏
页码:1206 / 1212
页数:7
相关论文
共 50 条
  • [1] Gabapentin for Postoperative Pain After Photorefractive Keratectomy: A Prospective, Randomized, Double-blind, Placebo-controlled Trial
    Lichtinger, Alejandro
    Purcell, Tracy L.
    Schanzlin, David J.
    Chayet, Arturo S.
    [J]. JOURNAL OF REFRACTIVE SURGERY, 2011, 27 (08) : 613 - 617
  • [2] A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED ADD-ON TRIAL OF LAMOTRIGINE IN PATIENTS WITH SEVERE EPILEPSY
    SANDER, JWAS
    PATSALOS, PN
    OXLEY, JR
    HAMILTON, MJ
    YUEN, WC
    [J]. EPILEPSY RESEARCH, 1990, 6 (03) : 221 - 226
  • [3] Ramosetron as an add-on therapy for refractory fibromyalgia: a randomized, double-blind, placebo-controlled trial
    Park, Dong-Jin
    Jeong, Hyemin
    Choi, Sung-Eun
    Kang, Ji-Hyoun
    Lee, Jung-Kil
    Lee, Shin-Seok
    [J]. RHEUMATOLOGY, 2024, 63 (09) : 2372 - 2378
  • [4] DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FLUNARIZINE AS ADD-ON THERAPY IN EPILEPSY
    OVERWEG, J
    BINNIE, CD
    MEIJER, JWA
    MEINARDI, H
    NUIJTEN, STM
    SCHMALTZ, S
    WAUQUIER, A
    [J]. EPILEPSIA, 1984, 25 (02) : 217 - 222
  • [5] Alleviating Social Pain: A Double-Blind, Randomized, Placebo-Controlled Trial of Forgiveness and Acetaminophen
    Slavich, George M.
    Shields, Grant S.
    Deal, Bailey D.
    Gregory, Amy
    Toussaint, Loren L.
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2019, 53 (12) : 1045 - 1054
  • [6] Sodium Benzoate Add-on Treatment for Refractory Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Lin, Chieh-Hsin
    Chang, Yue-Cune
    Lane, Hsien-Yuan
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 196 - 196
  • [7] Antipsychotic Effects of Celecoxib Add-On Haloperidol in Schizophrenia: A Randomized Double-Blind Placebo-Controlled Clinical Trial
    Zarghami, Mehran
    Dodangi, Nasrin
    Azari, Paria
    Khalilian, Alireza
    [J]. IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2024, 18 (01)
  • [8] Add-on melatonin improves sleep behavior in children with epilepsy: Randomized, double-blind, placebo-controlled trial
    Gupta, M
    Aneja, S
    Kohli, K
    [J]. JOURNAL OF CHILD NEUROLOGY, 2005, 20 (02) : 112 - 115
  • [9] Topiramate add-on in treatment-resistant schizophrenia:: A randomized, double-blind, placebo-controlled, crossover trial
    Tiihonen, J
    Halonen, P
    Wahlbeck, K
    Repo-Tiihonen, E
    Hyvärinen, S
    Eronen, M
    Putkonen, H
    Takala, P
    Mehtonen, IP
    Puck, M
    Oksanen, J
    Koskelainen, P
    Joffe, G
    Aer, J
    Hallikainen, T
    Ryynänen, IP
    Tupala, E
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (08) : 1012 - 1015
  • [10] N-Acetylcysteine in the Treatment of Pediatric Trichotillomania: A Randomized, Double-Blind, Placebo-Controlled Add-On Trial
    Bloch, Michael H.
    Panza, Kaitlyn E.
    Grant, Jon E.
    Pittenger, Christopher
    Leckman, James F.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2013, 52 (03): : 231 - 240